Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Down 1.8% – Time to Sell?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) shares dropped 1.8% during mid-day trading on Monday . The stock traded as low as $8.67 and last traded at $8.77. Approximately 76,371 shares traded hands during mid-day trading, a decline of 29% from the average daily volume of 107,073 shares. The stock had previously closed at $8.93.

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 1.8%

The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.13 and a current ratio of 6.63. The business has a fifty day moving average of $8.62 and a 200 day moving average of $8.08.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its earnings results on Monday, July 28th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. The company had revenue of $672.90 million during the quarter, compared to analysts’ expectations of $719.55 million. On average, equities analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.